Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
NLS Pharmaceutics Ltd. (NLSP) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.19M |
|
$0.00M |
|
$0.00M |
|
$1.19M |
|
$7.72M |
|
-- |
|
$2.74M |
|
$10.46M |
|
$-9.27M |
|
$-9.27M |
|
$-9.27M |
|
0.99M |
|
| Cash Flow Statement Financials | |
$-1.53M |
|
-- |
|
$1.19M |
|
$0.90M |
|
$0.55M |
|
$-0.34M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|